Form 4: AbCellera Biologics COO Exercises Stock Options

Veronique Lecault, COO of AbCellera Biologics, exercised stock options to acquire 83,334 common shares at $0.188 per share.

Summary

• Veronique Lecault, the Chief Operating Officer of AbCellera Biologics Inc., executed a transaction involving the company's common shares on June 21, 2024.
• Lecault exercised share options to acquire 83,334 common shares at a price of $0.188 per share.
• Following the reported transaction, Lecault directly owns 2,123,456 common shares.
• Lecault also has indirect ownership through her spouse (61,580 shares), Pacific Swell Capital Corp (7,155,008 shares), and Slomo Family Trust (273,630 shares).
• Lecault disclaims beneficial ownership of shares held by Pacific Swell Capital Corp and Slomo Family Trust except to the extent of her indirect pecuniary interest.
• She also directly owns 3,829,771 derivative securities (share options).

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard Form 4 filing. The exercise of options could be seen as a positive signal, but it's not a major event.

Positives

• The exercise of options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives and directors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the exercise of existing options, which slightly increases the number of outstanding shares.

Key Dates